苹果淫院

1st Place

Fulcra

Maria Calderbank,聽Emilie Davignon,聽Louis Tan, and聽Roseline Theroux (all Mechanical Engineering)

Lower back pain is the leading musculoskeletal issue affecting around 4 out of 5 individuals at聽least once in their lifetime. Fulcra uniquely targets chronic lower back pain. Our orthotic device is聽the first of its kind with its innovative ability to stabilize the spine, supporting the wearer during聽movement without developing dependencies. Heavy lifting and strenuous activities are common
risk factors that increase the development of lower back pain. Therefore, Fulcra鈥檚 orthosis is聽designed for labor-intensive jobs. It strikes the perfect balance between an ineffective, restrictive聽corset orthosis and a bulky, expensive exoskeleton.

2nd Place & Audience Favourite

MADAM

Catherine Xu,聽Karina Carlson,聽Liv Toft, and聽Palmyra Mendoza Cabrer (all Bioengineering)

Chlamydia is the most common STI worldwide, affecting 130M new people every year. While easily treated, it is often asymptomatic and spreads easily. MADAM aims to overcome barriers to frequent chlamydia screening through menstrual blood-based chlamydia tests, called MAD pads (Menstrual Analyte Detection pads). These tests would be antibody-based single-use rapid tests that can be done within the privacy of a user鈥檚 home, on their own time. The innovation would not only increase the accessibility of diagnosis for such a personal and widespread issue, but also act as a proof-of-concept for diagnostics using menstrual blood, an under-researched and noninvasive source of blood.

3rd Place

Endocare

Tanjin Sultana and聽Maria Delgopiatof (both Bioengineering)

Picture this: 176 million women worldwide silently battling endometriosis, a chronic disease often dismissed as menstrual pain. By providing women with an at-home, semi-invasive, and rapid testing process, Endocare is a game-changer in the early detection of this disease. . Endocare aims to facilitate the early detection of endometriosis to push women to get diagnosed and treated during the early stages of the disease. At Endocare, we strive to fill the gap in women鈥檚 healthcare and empower women one signal at a time!

AQDrain

Mark Tchinov,聽Adi Orlov,聽David Bettan, and聽Christopher Coluni (all Bioengineering)

AQDrain is a technologically-based product which serves to improve the lives of people suffering from glaucoma. This disease, currently affecting 80 million people worldwide and only expected to increase, is caused by fluid buildup within the eye. This increased fluid pressure, labeled intraocular pressure (IOP), is correlated with optic nerve damage, which ultimately leads to vision loss. Pressure reduction through eye drops, laser surgery and implants are common treatments. These methods of treating glaucoma lack in their effective regulation of this fluid pressure. Our product is designed to maintain an IOP within an optimal, healthy range. The regulation of IOP plays a vital role in preserving the shape of the eye, and therefore allowing for the proper functioning of the optic nerve and optimal visual acuity.

Clarity

James Darby and聽Alexander Mackenzie (Software Engineering and Math + Computer Science)

Clarity is a natural language input, user guided, content recommendation system; for more mindful, healthy & productive social media usage. Clarity will leverage semantic content classification and LLM鈥檚 to allow users to specify their conscious social media content experience preferences in natural language. This will redefine recommendation systems from algorithms that maximize user engagement and retention, stealing time and attention, to providing the most valuable content to the user while guarding against addiction and protecting their time.